Last reviewed · How we verify

NCT05276453

Effect of Pressotherapy on Health Outcomes in Patients With Chronic Stroke

Completed NA Last updated 15 March 2024
What this trial tests

NA trial testing GMove Suit in Stroke in 31 participants. Completed in 30 July 2022.

Timeline
1 April 2022
Primary endpoint
30 July 2022
30 July 2022

Quick facts

Lead sponsorUniversity of Winchester
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment31
Start date1 April 2022
Primary completion30 July 2022
Estimated completion30 July 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Winchester

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to recruit stroke patients to either wearing a lower-limb compression (GMove) suit, daily, for 12 weeks, or to a normal therapy control group. Vascular, functional and quality of life outcomes will be collected before and after randomisation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of using home-based dynamic intermittent pneumatic compression therapy during periods of physical activity on functional and vascular health outcomes in chronic stroke: A randomized controlled clinical trial.
    Faulkner J, Paine E, Hudson N, Hannah S, et al · · 2025 · cited 1× · PMID 39964987 · DOI 10.1371/journal.pone.0318942

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Winchester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276453.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing